PharmAla Biotech Holdings, Inc.(TSE:MDMA)
CA$0.150.00 (0.00%)
TSE:MDMA
PharmAla Biotech Holdings, Inc. financials statements
CA$0.15
At close:0.00 (0.00%)
Want to see TSE:MDMA full AI Analyst Report?
PharmAla Biotech Holdings, Inc. (MDMA) Income Statement
67 Followers
PharmAla Biotech Holdings, Inc. Income Statement
Last quarter (Q3 2026), PharmAla Biotech Holdings, Inc.'s total revenue was C$513.23K, an increase of 279.70% from the same quarter last year. In Q3, PharmAla Biotech Holdings, Inc.'s net income was C$-499.76K. See PharmAla Biotech Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Nov 25 | Nov 24 | Nov 23 | Nov 22 | Aug 21 |
|---|---|---|---|---|---|
| C$ 605.50K | C$ 1.04M | C$ 532.00K | C$ 78.07K | C$ 0.00 | |
| C$ -845.17K | C$ 887.44K | C$ 454.10K | C$ 75.78K | C$ -303.00 | |
| C$ 1.31M | C$ 1.53M | C$ 1.22M | C$ 1.06M | C$ 2.51M | |
| Depreciation and Amortization | C$ 117.05K | C$ 70.21K | C$ 52.77K | C$ 12.13K | C$ 303.00 |
| C$ -2.07M | C$ -573.36K | C$ -710.18K | C$ -973.45K | C$ -2.51M | |
| C$ -2.15M | C$ -643.57K | C$ -762.95K | C$ -985.58K | C$ -2.51M | |
| C$ -22.02K | C$ -180.03K | C$ -16.86K | C$ 0.00 | C$ 0.00 | |
| C$ -2.18M | C$ -823.60K | C$ -779.81K | C$ -985.58K | C$ -2.51M | |
| C$ -2.18M | C$ -823.60K | C$ -779.81K | C$ -985.58K | C$ -2.51M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.02 | C$ -0.01 | C$ -0.01 | C$ -0.01 | C$ -0.03 |
| Diluted EPS | C$ -0.02 | C$ -0.01 | C$ -0.01 | C$ -0.01 | C$ -0.03 |
| Weighted Average Shares Outstanding | 99.58M | 88.57M | 84.53M | 83.00M | 83.00M |
| Weighted Average Shares Outstanding (Diluted) | 99.58M | 88.57M | 84.53M | 83.00M | 83.00M |
Currency in CAD
